Clinical Trials
5/5
5/5

[┐∵]-

Clinical Trial Studies API

Clinical trial studies API for fetching all content for a small set of study records
The clinical trial studies API of Clinical Trials delivers data with the purpose of fetching all content for a small set of study records. The API is used by small business, medium business and enterprises, several ideas of the type of company that uses it are healthcare and medicine platforms, researchers in medicine field and more. The customers use the data within the healthcare, medicine and pharmaceutical industry. The database has coverage in The US. There are endless programs that are being developed using the clinical trial studies API. Programmers constantly come with new ideas to use the API, here we have a few potential cases; providing research text on clinical trials for medicine-related platforms, mobile applications, websites, research and more and surely there are much more customers can realise. With this system customers can filter determined by fmt, expr, min_rnk, max_rnk, fields and field to attain the response output customers need.

Clinical Trial Studies API endpoints

GET

/api/query/full_studies

Connect to the full clinical trial studies API endpoint; /api/query/full_studies by sending a GET request for data to the endpoint using the the available parameters and get the output as in the example data output. This endpoint is built for fetching all content for a small set of study records. To get the response desired, use the parameters and objects as described in the object and description table. The API documentation works with all leading programming languages, just attach your API key parameter to the data endpoint URL and set it to your private API key to start receiving the requested data. Place the endpoint into the URL to execute the data request.

Filtering parameters for clinical trial studies data

See below the filtering methods available with the clinical trial studies data.
Filters
fmt field
expr
min_rnk
max_rnk
fields

API object attributes

Attain the required data from the system with the applicable parameters and the table to clarify the objects.
Objects Description
Rank
Study
ProtocolSection
IdentificationModule
NCTId
OrgStudyIdInfo
OrgStudyId
SecondaryIdInfoList
SecondaryIdInfo
SecondaryId
SecondaryIdType
SecondaryIdDomain
Organization
OrgFullName
OrgClass
BriefTitle
OfficialTitle
Acronym
StatusModule
StatusVerifiedDate
etc etc

Clinical trial studies response output

Here is an example data output of the endpoint call. There is more data accessible, this example is limited to make it more readable. Opt-in for the API system to receive the complete response output.
				
					{
  "FullStudiesResponse":{
    "APIVrs":"1.01.05",
    "DataVrs":"2022:11:17 23:33:37.354",
    "Expression":"heart attack",
    "NStudiesAvail":433955,
    "NStudiesFound":9364,
    "MinRank":1,
    "MaxRank":1,
    "NStudiesReturned":1,
    "FullStudies":[
      {
        "Rank":1,
        "Study":{
          "ProtocolSection":{
            "IdentificationModule":{
              "NCTId":"NCT01874691",
              "OrgStudyIdInfo":{
                "OrgStudyId":"2011BAI11B02-A"
              },
              "SecondaryIdInfoList":{
                "SecondaryIdInfo":[
                  {
                    "SecondaryId":"2011BAI11B02",
                    "SecondaryIdType":"Other Grant/Funding Number",
                    "SecondaryIdDomain":"Chinese Ministry of Science and Technology"
                  }
                ]
              },
              "Organization":{
                "OrgFullName":"Chinese Academy of Medical Sciences, Fuwai Hospital",
                "OrgClass":"OTHER"
              },
              "BriefTitle":"China Acute Myocardial Infarction Registry",
              "OfficialTitle":"China Acute Myocardial Infarction Registry",
              "Acronym":"CAMIRegistry"
            },
            "StatusModule":{
              "StatusVerifiedDate":"May 2022",
              "OverallStatus":"Completed",
              "ExpandedAccessInfo":{
                "HasExpandedAccess":"No"
              },
              "StartDateStruct":{
                "StartDate":"January 2013",
                "StartDateType":"Actual"
              },
              "PrimaryCompletionDateStruct":{
                "PrimaryCompletionDate":"December 2016",
                "PrimaryCompletionDateType":"Actual"
              },
              "CompletionDateStruct":{
                "CompletionDate":"December 2016",
                "CompletionDateType":"Actual"
              },
              "StudyFirstSubmitDate":"June 4, 2013",
              "StudyFirstSubmitQCDate":"June 7, 2013",
              "StudyFirstPostDateStruct":{
                "StudyFirstPostDate":"June 11, 2013",
                "StudyFirstPostDateType":"Estimate"
              },
              "LastUpdateSubmitDate":"May 7, 2022",
              "LastUpdatePostDateStruct":{
                "LastUpdatePostDate":"May 12, 2022",
                "LastUpdatePostDateType":"Actual"
              }
            },
            "SponsorCollaboratorsModule":{
              "ResponsibleParty":{
                "ResponsiblePartyType":"Principal Investigator",
                "ResponsiblePartyInvestigatorFullName":"Yuejin Yang",
                "ResponsiblePartyInvestigatorTitle":"Doctor",
                "ResponsiblePartyInvestigatorAffiliation":"Chinese Academy of Medical Sciences, Fuwai Hospital"
              },
              "LeadSponsor":{
                "LeadSponsorName":"Chinese Academy of Medical Sciences, Fuwai Hospital",
                "LeadSponsorClass":"OTHER"
              }
            },
            "OversightModule":{
              "OversightHasDMC":"Yes"
            },
            "DescriptionModule":{
              "BriefSummary":"This study is to build a Chinese national registry and surveillance system for acute myocardial infarction(AMI) to obtain real-world information about current status of characteristics, risk factors, diagnosis, treatment and outcomes of Chinese AMI patients; And to propose scientific precaution strategies aimed to prevent effectively from the incidence of AMI; And to optimize the management and outcomes of AMI patients through implementation of guideline recommendations in clinical practice, and analysis and development of effective treatment strategies; And to create cost-effective assessment system.",
              "DetailedDescription":"The aim of the study is to establish the national platform for surveillance, clinical research and translational medicine in China, designed to facilitate efforts to improve the quality of AMI patient care and thus decrease morbidity and mortality associated with AMI."
            },
            "ConditionsModule":{
              "ConditionList":{
                "Condition":[
                  "Acute Myocardial Infarction"
                ]
              },
              "KeywordList":{
                "Keyword":[
                  "acute myocardial infarction",
                  "China",
                  "Registry"
                ]
              }
            },
            "DesignModule":{
              "StudyType":"Observational",
              "PatientRegistry":"Yes",
              "TargetDuration":"2 Years",
              "DesignInfo":{
                "DesignObservationalModelList":{
                  "DesignObservationalModel":[
                    "Case-Only"
                  ]
                },
                "DesignTimePerspectiveList":{
                  "DesignTimePerspective":[
                    "Prospective"
                  ]
                }
              },
              "EnrollmentInfo":{
                "EnrollmentCount":"20000",
                "EnrollmentType":"Actual"
              }
            },
            "ArmsInterventionsModule":{
              "ArmGroupList":{
                "ArmGroup":[
                  {
                    "ArmGroupLabel":"acute myocardial infarction",
                    "ArmGroupDescription":"acute myocardial infarction including ST-elevation and non ST-elevation myocardial infarction"
                  }
                ]
              }
            },
            "OutcomesModule":{
              "PrimaryOutcomeList":{
                "PrimaryOutcome":[
                  {
                    "PrimaryOutcomeMeasure":"In-hospital mortality of the patients with acute myocardial infarction in different-level hospitals across China",
                    "PrimaryOutcomeDescription":"Different-level hospitals include Provincial-level, city-level, County-level hospitals from all over China.",
                    "PrimaryOutcomeTimeFrame":"the duration of hospital stay, an expected average of 2 weeks"
                  }
                ]
              },
              "SecondaryOutcomeList":{
                "SecondaryOutcome":[
                  {
                    "SecondaryOutcomeMeasure":"The rate of the application of thrombolysis and primary percutaneous coronary intervention for Chinese patients with acute myocardial infarction in different-level hospitals",
                    "SecondaryOutcomeDescription":"In different-level hospitals, How many patients with acute myocardial infarction receive thrombolysis and/or primary percutaneous coronary intervention within 24 hours from the onset,respectively?",
                    "SecondaryOutcomeTimeFrame":"24 hours"
                  },{
                    "SecondaryOutcomeMeasure":"provoking factors of Chinese patients with AMI across different areas and different population in China",
                    "SecondaryOutcomeDescription":"The different factors that can provoke the onset of acute myocardial infarction, for example, excess exercise, overload work, heavy smoking, heavy drinking of alcohol and so on.",
                    "SecondaryOutcomeTimeFrame":"24 hours"
                  }
                ]
              },
              "OtherOutcomeList":{
                "OtherOutcome":[
                  {
                    "OtherOutcomeMeasure":"the in-hospital cost of Chinese patients with acute myocardial infarction",
                    "OtherOutcomeTimeFrame":"the duration of hospital stay, an expected average of 2 weeks"
                  }
                ]
              }
            },
            "EligibilityModule":{
              "EligibilityCriteria":"Inclusion Criteria:Eligible patients must be admitted within 7 days of acute ischemic symptoms and diagnosed acute ST-elevation or non ST-elevation myocardial infarction. Diagnosis criteria must meet Universal Definition for AMI (2012). All participating hospitals are required to enroll consecutive patients with AMI.Exclusion Criteria:Myocardial infarction related to percutaneous coronary intervention and coronary artery bypass grafting.",
              "HealthyVolunteers":"No",
              "Gender":"All",
              "StdAgeList":{
                "StdAge":[
                  "Child",
                  "Adult",
                  "Older Adult"
                ]
              },
              "StudyPopulation":"Eligible patients admitted within 7 days of acute ischemic symptoms and diagnosed acute ST-elevation or non ST-elevation myocardial infarction.",
              "SamplingMethod":"Probability Sample"
            },
            "ContactsLocationsModule":{
              "OverallOfficialList":{
                "OverallOfficial":[
                  {
                    "OverallOfficialName":"Yuejin Yang, MD.",
                    "OverallOfficialAffiliation":"Fuwai Hospital, Chinse Academy of Medical Sciences",
                    "OverallOfficialRole":"Study Chair"
                  }
                ]
              },
              "LocationList":{
                "Location":[
                  {
                    "LocationFacility":"Fuwai Hospital",
                    "LocationCity":"Beijing",
                    "LocationState":"Beijing",
                    "LocationZip":"100037",
                    "LocationCountry":"China"
                  }
                ]
              }
            },
            "ReferencesModule":{
              "ReferenceList":{
                "Reference":[
                  {
                    "ReferencePMID":"20031882",
                    "ReferenceType":"background",
                    "ReferenceCitation":"Peterson ED, Roe MT, Rumsfeld JS, Shaw RE, Brindis RG, Fonarow GC, Cannon CP. A call to ACTION (acute coronary treatment and intervention outcomes network): a national effort to promote timely clinical feedback and support continuous quality improvement for acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2009 Sep;2(5):491-9. doi: 10.1161/CIRCOUTCOMES.108.847145."
                  },{
                    "ReferencePMID":"35784538",
                    "ReferenceType":"derived",
                    "ReferenceCitation":"Cui K, Fu R, Yang J, Xu H, Yin D, Song W, Wang H, Zhu C, Feng L, Wang Z, Wang Q, Lu Y, Dou K, Yang Y. Admission Blood Glucose and 2-Year Mortality After Acute Myocardial Infarction in Patients With Different Glucose Metabolism Status: A Prospective, Nationwide, and Multicenter Registry. Front Endocrinol (Lausanne). 2022 Jun 15;13:898384. doi: 10.3389/fendo.2022.898384. eCollection 2022."
                  },{
                    "ReferencePMID":"35772392",
                    "ReferenceType":"derived",
                    "ReferenceCitation":"Cui K, Fu R, Yang J, Xu H, Yin D, Song W, Wang H, Zhu C, Feng L, Wang Z, Wang Q, Lu Y, Dou K, Yang Y; CAMI Registry Investigators. Stress hyperglycemia ratio and long-term mortality after acute myocardial infarction in patients with and without diabetes: A prospective, nationwide, and multicentre registry. Diabetes Metab Res Rev. 2022 Oct;38(7):e3562. doi: 10.1002/dmrr.3562. Epub 2022 Jul 13."
                  },{
                    "ReferencePMID":"34631809",
                    "ReferenceType":"derived",
                    "ReferenceCitation":"Shi W, Ni L, Yang J, Fan X, Yu M, Yang H, Yu M, Yang Y; China Acute Myocardial Infarction (CAMI) Registry study group. The Clinical Impact of Proton Pump Inhibitors When Co-Administered With Dual Antiplatelet Therapy in Patients Having Acute Myocardial Infarction With Low Risk of Gastrointestinal Bleeding: Insights From the China Acute Myocardial Infarction Registry. Front Cardiovasc Med. 2021 Sep 22;8:685072. doi: 10.3389/fcvm.2021.685072. eCollection 2021."
                  },{
                    "ReferencePMID":"34493500",
                    "ReferenceType":"derived",
                    "ReferenceCitation":"Shi W, Fan X, Yang J, Ni L, Su S, Yu M, Yang H, Yu M, Yang Y; China Acute Myocardial Infarction(CAMI) Registry Study Group. In-hospital gastrointestinal bleeding in patients with acute myocardial infarction: incidence, outcomes and risk factors analysis from China Acute Myocardial Infarction Registry. BMJ Open. 2021 Sep 7;11(9):e044117. doi: 10.1136/bmjopen-2020-044117."
                  },{
                    "ReferencePMID":"31567475",
                    "ReferenceType":"derived",
                    "ReferenceCitation":"Song CX, Fu R, Yang JG, Xu HY, Gao XJ, Wang CY, Zheng Y, Jia SB, Dou KF, Yang YJ; CAMI Registry study group. Angiographic characteristics and in-hospital mortality among patients with ST-segment elevation myocardial infarction presenting without typical chest pain: an analysis of China Acute Myocardial Infarction registry. Chin Med J (Engl). 2019 Oct 5;132(19):2286-2291. doi: 10.1097/CM9.0000000000000432."
                  },{
                    "ReferencePMID":"31515430",
                    "ReferenceType":"derived",
                    "ReferenceCitation":"Song C, Fu R, Li S, Yang J, Wang Y, Xu H, Gao X, Liu J, Liu Q, Wang C, Dou K, Yang Y. Simple risk score based on the China Acute Myocardial Infarction registry for predicting in-hospital mortality among patients with non-ST-segment elevation myocardial infarction: results of a prospective observational cohort study. BMJ Open. 2019 Sep 12;9(9):e030772. doi: 10.1136/bmjopen-2019-030772."
                  },{
                    "ReferencePMID":"31471442",
                    "ReferenceType":"derived",
                    "ReferenceCitation":"Song C, Fu R, Dou K, Yang J, Xu H, Gao X, Wang H, Liu S, Fan X, Yang Y. Association between smoking and in-hospital mortality in patients with acute myocardial infarction: results from a prospective, multicentre, observational study in China. BMJ Open. 2019 Aug 30;9(8):e030252. doi: 10.1136/bmjopen-2019-030252."
                  },{
                    "ReferencePMID":"31255895",
                    "ReferenceType":"derived",
                    "ReferenceCitation":"Leng W, Yang J, Fan X, Sun Y, Xu H, Gao X, Wang Y, Li W, Xu Y, Han Y, Jia S, Zheng Y, Yang Y; behalf CAMI Registry investigators. Contemporary invasive management and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction in China: Findings from China Acute Myocardial Infarction (CAMI) Registry. Am Heart J. 2019 Sep;215:1-11. doi: 10.1016/j.ahj.2019.05.015. Epub 2019 Jun 6."
                  },{
                    "ReferencePMID":"30807351",
                    "ReferenceType":"derived",
                    "ReferenceCitation":"Fu R, Song CX, Dou KF, Yang JG, Xu HY, Gao XJ, Liu QQ, Xu H, Yang YJ. Differences in symptoms and pre-hospital delay among acute myocardial infarction patients according to ST-segment elevation on electrocardiogram: an analysis of China Acute Myocardial Infarction (CAMI) registry. Chin Med J (Engl). 2019 Mar 5;132(5):519-524. doi: 10.1097/CM9.0000000000000122."
                  },{
                    "ReferencePMID":"28052755",
                    "ReferenceType":"derived",
                    "ReferenceCitation":"Dai Y, Yang J, Gao Z, Xu H, Sun Y, Wu Y, Gao X, Li W, Wang Y, Gao R, Yang Y; CAMI Registry study group. Atrial fibrillation in patients hospitalized with acute myocardial infarction: analysis of the china acute myocardial infarction (CAMI) registry. BMC Cardiovasc Disord. 2017 Jan 4;17(1):2. doi: 10.1186/s12872-016-0442-9."
                  },{
                    "ReferencePMID":"27530939",
                    "ReferenceType":"derived",
                    "ReferenceCitation":"Sun H, Yang YJ, Xu HY, Yang JG, Gao XJ, Wu Y, Li W, Wang Y, Liu J, Jin C, Song L; CAMI Registry Study Group. [Survey of medical care resources of acute myocardial infarction in different regions and levels of hospitals in China]. Zhonghua Xin Xue Guan Bing Za Zhi. 2016 Jul 24;44(7):565-9. doi: 10.3760/cma.j.issn.0253-3758.2016.07.003. Chinese."
                  }
                ]
              }
            }
          },
          "DerivedSection":{
            "MiscInfoModule":{
              "VersionHolder":"November 18, 2022"
            },
            "ConditionBrowseModule":{
              "ConditionMeshList":{
                "ConditionMesh":[
                  {
                    "ConditionMeshId":"D000009203",
                    "ConditionMeshTerm":"Myocardial Infarction"
                  },{
                    "ConditionMeshId":"D000007238",
                    "ConditionMeshTerm":"Infarction"
                  }
                ]
              },
              "ConditionAncestorList":{
                "ConditionAncestor":[
                  {
                    "ConditionAncestorId":"D000007511",
                    "ConditionAncestorTerm":"Ischemia"
                  },{
                    "ConditionAncestorId":"D000010335",
                    "ConditionAncestorTerm":"Pathologic Processes"
                  },{
                    "ConditionAncestorId":"D000009336",
                    "ConditionAncestorTerm":"Necrosis"
                  },{
                    "ConditionAncestorId":"D000017202",
                    "ConditionAncestorTerm":"Myocardial Ischemia"
                  },{
                    "ConditionAncestorId":"D000006331",
                    "ConditionAncestorTerm":"Heart Diseases"
                  },{
                    "ConditionAncestorId":"D000002318",
                    "ConditionAncestorTerm":"Cardiovascular Diseases"
                  },{
                    "ConditionAncestorId":"D000014652",
                    "ConditionAncestorTerm":"Vascular Diseases"
                  }
                ]
              },
              "ConditionBrowseLeafList":{
                "ConditionBrowseLeaf":[
                  {
                    "ConditionBrowseLeafId":"M11307",
                    "ConditionBrowseLeafName":"Myocardial Infarction",
                    "ConditionBrowseLeafAsFound":"Myocardial Infarction",
                    "ConditionBrowseLeafRelevance":"high"
                  },{
                    "ConditionBrowseLeafId":"M9434",
                    "ConditionBrowseLeafName":"Infarction",
                    "ConditionBrowseLeafAsFound":"Infarction",
                    "ConditionBrowseLeafRelevance":"high"
                  },{
                    "ConditionBrowseLeafId":"M9695",
                    "ConditionBrowseLeafName":"Ischemia",
                    "ConditionBrowseLeafRelevance":"low"
                  },{
                    "ConditionBrowseLeafId":"M11436",
                    "ConditionBrowseLeafName":"Necrosis",
                    "ConditionBrowseLeafRelevance":"low"
                  },{
                    "ConditionBrowseLeafId":"M5698",
                    "ConditionBrowseLeafName":"Coronary Artery Disease",
                    "ConditionBrowseLeafRelevance":"low"
                  },{
                    "ConditionBrowseLeafId":"M18658",
                    "ConditionBrowseLeafName":"Myocardial Ischemia",
                    "ConditionBrowseLeafRelevance":"low"
                  },{
                    "ConditionBrowseLeafId":"M8571",
                    "ConditionBrowseLeafName":"Heart Diseases",
                    "ConditionBrowseLeafRelevance":"low"
                  },{
                    "ConditionBrowseLeafId":"M16552",
                    "ConditionBrowseLeafName":"Vascular Diseases",
                    "ConditionBrowseLeafRelevance":"low"
                  },{
                    "ConditionBrowseLeafId":"T170",
                    "ConditionBrowseLeafName":"Acute Graft Versus Host Disease",
                    "ConditionBrowseLeafRelevance":"low"
                  }
                ]
              },
              "ConditionBrowseBranchList":{
                "ConditionBrowseBranch":[
                  {
                    "ConditionBrowseBranchAbbrev":"BC14",
                    "ConditionBrowseBranchName":"Heart and Blood Diseases"
                  },{
                    "ConditionBrowseBranchAbbrev":"BC23",
                    "ConditionBrowseBranchName":"Symptoms and General Pathology"
                  },{
                    "ConditionBrowseBranchAbbrev":"All",
                    "ConditionBrowseBranchName":"All Conditions"
                  },{
                    "ConditionBrowseBranchAbbrev":"Rare",
                    "ConditionBrowseBranchName":"Rare Diseases"
                  }
                ]
              }
            }
          }
        }
      }
    ]
  }
}
				
			

Software development kits

Use whichever of the filter parameters to choose the full clinical trial studies data that is needed. The API system delivers response as JSON format and for programming languages such as; Javascript, Angular, JQuery, JAVA, R, C#, NodeJS, PHP, Python, Ruby, VueJS, Strest, Swift, Rust, Go and Scala there are SDKs accessible, simply email for it and it should be provided quickly.

Clinical Trial Studies API pricing

Before you decide to purchase API access you may inquire into trials and samples of the clinical trial studies data. E-mail and request for the test access and you will be able to work with the data. It won’t be without limits but it will be sufficient to test the system.

Cost and price of the API

You may promptly start developing with Clinical Trials API with the price tag set monthly from $0 or directly contact the provider to learn more information now.
Option Price
Monthly subscription From $0/month
Variable pricing no

Free Trial

Free trial is available

Alternative options

Clinical Trials

Clinical Study Fields API
5/5
5/5
Get connected to the Clinical Study Fields API provider to directly get detailed data for fetching values from selected API fields for a large set of clinical trial study records purposes easily. The clinical study fields API is the top tool to precisely fetch Healthcare data to your API client.

Clinical Trials

Clinical Study Values API
5/5
5/5
This clinical study values API is inclusive of a gigantic volume of Healthcare data with the full elements you need. Clinical Study Values API proposes accurate providing study values on clinical trials for medicine-related platforms, mobile applications, websites, research and more data for advancing apps, online services, tools, programs, market inquiries and much more.

Drugbank

Pharmacology API
5/5
5/5
This pharmacology API offers a gigantic amount of Healthcare data including the complete elements you require. Pharmacology API ensures you get the best external data solutions to develop projects for fetching pharmacology information related to drugs purposes.

Drugbank

Drug Products API
5/5
5/5
Drug Products API provides Healthcare data to build fetching a list of commercially available products in Canada and the United States that contain the drug purposes to advance companies around the world. This drug products API is inclusive of a massive amount of Healthcare data with all the details you want.

Drugbank

Drug Prices API
5/5
5/5
This drug prices API offers a gigantic amount of Healthcare data together with the full elements you want. Get connected to the Drug Prices API provider to start receiving precise data for fetching unit drug prices and similar purposes today.

Drugbank

Drug Classification API
5/5
5/5
Drug Classification API grants external data solutions to create data-oriented products for fetching a description of the hierarchical chemical classification of the drug objectives. Healthcare data via drug classification API offers the right information to make sure you can develop advanced online products.

Sign up for Clinical Trials clinical trial studies API

Get Data Access

~[ ∵ ]~

Sign-up Succesful

Wait for the Data